Page last updated: 2024-08-22

zalcitabine and Delayed Effects, Prenatal Exposure

zalcitabine has been researched along with Delayed Effects, Prenatal Exposure in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Colan, SD; Mittleman, MA; Oleske, JM; Patel, K; Seage, GR; Van Dyke, RB	1

Other Studies

1 other study(ies) available for zalcitabine and Delayed Effects, Prenatal Exposure

Article	Year
The impact of HAART on cardiomyopathy among children and adolescents perinatally infected with HIV-1. AIDS (London, England), 2012, Oct-23, Volume: 26, Issue:16 Topics: Adolescent; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cardiomyopathies; Cardiotonic Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Cohort Studies; Digoxin; Female; Follow-Up Studies; HIV Seropositivity; Humans; Infant; Infectious Disease Transmission, Vertical; Male; Pregnancy; Prenatal Exposure Delayed Effects; Proportional Hazards Models; Prospective Studies; Treatment Outcome; United States; Zalcitabine; Zidovudine	2012

Article

Year

The impact of HAART on cardiomyopathy among children and adolescents perinatally infected with HIV-1.

AIDS (London, England), 2012, Oct-23, Volume: 26, Issue:16

Topics: Adolescent; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cardiomyopathies; Cardiotonic Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Cohort Studies; Digoxin; Female; Follow-Up Studies; HIV Seropositivity; Humans; Infant; Infectious Disease Transmission, Vertical; Male; Pregnancy; Prenatal Exposure Delayed Effects; Proportional Hazards Models; Prospective Studies; Treatment Outcome; United States; Zalcitabine; Zidovudine

2012